[ad_1]
The World Health Organization (WHO) said on Wednesday the only approved vaccine against malaria should be widely used on children in Africa, potentially a major advance against a disease that kills hundreds of thousands of people annually.
LIVE: Media briefing with @DrTedros on #malaria vaccine recommendations. #EndMalaria https://t.co/c5OjRTRPlK
— World Health Organization (WHO) (@WHO) October 6, 2021
The recommendation is for RTS,S, or Mosquirix, a vaccine developed by British drugmaker GlaxoSmithKline. It was jointly announced in Geneva by the WHO’s top advisory bodies for malaria and immunization, the Malaria Policy Advisory Group and the Strategic Advisory Group of Experts on Immunisation.
[ad_2]
Source link